Sales of pharmaceutical products through retail pharmacy outlets in the world's 10 leading markets increased 13% in the first three months of 1995 to reach a total of $34.17 billion worldwide, according to figures published last week by IMS International. This compares to a rise of 12% for the first two months of this year, and an increase of only 1% for the first quarter of 1994.
Sales in the USA rose 13% to $13.86 billion in January-march 1995, while Japan's growth was the highest of any market, at 20%, reaching a total of $6.21 billion, compared with a fall of 6% in first-quarter 1994. the top seven European markets had combined sales of $13.22 billion in the quarter, an advance of 9%.
Spanish Sales Up 15% Within the European top seven, the fastest growth was reported for the Spanish market, rising 15% to $1.16 billion. This was followed by Germany, which advanced 11% to $4.08 billion and the UK, which rose 10% to $1.50 billion. Sales in both France and the Netherlands were up 9%, reaching $3.58 billion and $490 million respectively, while turnover in belgium was up 7% to $474 million and Italy rose 4% to $1.93 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze